-TheWire.in Professor Andrew Pollard tells Karan Thapar why India's 12-16 week Covishield gap makes sense, but refutes claim a single dose AstraZeneca vaccine is likely soon. The Chief Investigator of AstraZeneca and the Director of the Oxford Vaccine Group has, in this interview, addressed the present controvery over how long the gap between two doses of Covishield should be, clearly endorsing the Centre’s present policy of a 12-16 week gap. Professor Sir Andrew...

-PTI/ Business Standard The findings of the study are under consideration for publication in a peer-reviewed medical journal A multi-centre study on a cohort of over 31,000 vaccinated healthcare workers of a leading private facility, spanning across the country, has found that Covid vaccine provided protection against infection in "95 per cent" of the beneficiaries, hospital authorities claimed on Wednesday. The study by Apollo Hospitals took place over four and a half months,...

-Newsclick.in Large-scale privatisation of the vaccination programme is happening, cutting of low-paying sections of the population. Yet, other discrepancies remain, calling for an audit by CAG. India is facing an acute vaccine shortage. The impression that generally prevails is that this shortage is because while production capacity is slow to increase, there has been a sudden spurt in vaccine demand since vaccination is now open for the 18-44 years age group in...

-The Hindu Official secrecy on pandemic policies aggravates a crisis In August 2020, the Modi government constituted the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) as a nodal agency on all matters related to vaccine administration and rollout. Asked under the Right to Information (RTI) Act for details of the NEGVAC’s meetings, the Health Ministry, which anchors the expert group, replied that it does not know where the concerned documents...

-The Telegraph Researchers will document the vaccination status of infected patients admitted with severe disease at 11 sites across the country Medical researchers have launched India’s first study to measure the real-world effectiveness of Covishield and Covaxin by documenting the vaccination status of Covid-19 patients admitted with severe disease at 11 sites across the country. The study by the National Institute of Epidemiology (NIE), Chennai, a unit of the Indian Council of Medical...